Bone marrow or stem cell transplantation

Oral

Rebooting Autoimmunity After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients by Newly-generated Regulatory t- and B-cells

Friday, June 16
6:15 PM - 7:30 PM

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) is more effective to treat severe systemic sclerosis (SSc) than conventional immunosuppression (IS). However, its therapeutic mechanisms still need to be understood. Thirty-one transplanted and sixteen IS-treated SSc patients had PBMCs collected before and semiannually until 36 months after inclusion. Immune reconstitution analyses evidenced higher thymic function than baseline at 24 months as measured by β- and signal-joint (sj)-TCR excision circles (sjTREC) RT-qPCR, correlating with CD3+CD4+CD31+CD45RA+ recent thymic emigrants exportation. The TCR new generation sequencing (NGS) depicted higher TCR diversity from 1-2 years post-transplant. Additionally, at 6 months post-AHSCT, increased numbers of CD8+CD28-CD57+ exhausted T-cells correlated with reduced telomere T/S ratio and reduced TCR diversity. CD4+CD25hiFoxP3+(GITR+/CTLA-4+) regulatory T-cells (Tregs) increased at 12 months post-transplantation, correlating with sjTREC values, having higher CD45RA expression and IL-10 production after anti-CD3/CD28 stimulation than baseline. Bone marrow output of naive B-cells, as quantified by coding-joint (Cj) and sj-kappa-deleting recombination excision circles (sjKREC) RT-qPCR, increased from 12-36 months post-AHSCT, resulting in reduced B-cell division (N=LOG(Cj/sjKREC)/LOG2) and persistent increase of CD19+CD27-IgD+ naive and CD19+CD38lowIgD+ Bm2 B-cell counts. Finally, CD19+CD24hiCD38hi regulatory B-cell (Breg) counts increased from 6-12 months post-AHSCT, correlating with sjKREC values and presenting higher IL-10 production after CpG±CD40L stimulation than baseline. Skin biopsies presented higher IL-10 expression at 6-12 months post-transplantation. Six transplanted patients relapsed, presenting lower FoxP3, GITR and CTLA-4 expressions, reduced Breg counts and lower TCR diversity. Our results suggest that increased counts of newly-generated regulatory B- and T-cells post-AHSCT are associated with clinical improvement in SSc patients.

Lucas C. M.. Arruda

Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo

Presentation(s):

    Send Email for Lucas Arruda

    João R. Lima-Júnior

    INCTC, Regional Hemotherapy Center of the Ribeirão Preto Medical School, University of São Paulo

    Presentation(s):

      Send Email for João R. Lima-Júnior

      Emmanuel Clave

      Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie

      Presentation(s):

        Send Email for Emmanuel Clave

        Daniela A. Moraes

        Division of Clinical Immunology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo

        Presentation(s):

          Send Email for Daniela A. Moraes

          Corinne Douay

          Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie

          Presentation(s):

            Send Email for Corinne Douay

            Isabelle Fournier

            Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie

            Presentation(s):

              Send Email for Isabelle Fournier

              Hélène Moins-Teisserenc

              Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie

              Presentation(s):

                Send Email for Hélène Moins-Teisserenc

                Dimas T. Covas

                INCTC, Regional Hemotherapy Center of the Ribeirão Preto Medical School, University of São Paulo

                Presentation(s):

                  Send Email for Dimas T. Covas

                  Kelen C. R. Malmegrim

                  INCTC, Regional Hemotherapy Center of the Ribeirão Preto Medical School, University of São Paulo

                  Presentation(s):

                    Send Email for Kelen C. R. Malmegrim

                    Dominique Farge

                    Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie

                    Presentation(s):

                      Send Email for Dominique Farge

                      Leandra N. Z. Ramalho

                      Department of Pathology, Ribeirão Preto Medical School, University of São Paulo

                      Presentation(s):

                        Send Email for Leandra N. Z. Ramalho

                        Maria Carolina Oliveira

                        Division of Clinical Immunology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo

                        Presentation(s):

                          Send Email for Maria Carolina Oliveira

                          Antoine Toubert

                          INSERM U1160, Université Paris Diderot, APHP, Hôpital Saint-Louis

                          Presentation(s):

                            Send Email for Antoine Toubert


                            Assets

                            Rebooting Autoimmunity After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients by Newly-generated Regulatory t- and B-cells



                            Attendees who have favorited this

                            Send Email for Rebooting Autoimmunity After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients by Newly-generated Regulatory t- and B-cells